Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study (Q43750037)

From Wikidata
Jump to navigation Jump to search
scientific article published in October 2001
edit
Language Label Description Also known as
English
Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study
scientific article published in October 2001

    Statements

    Comparison of the oral direct thrombin inhibitor ximelagatran with enoxaparin as prophylaxis against venous thromboembolism after total knee replacement: a phase 2 dose-finding study (English)
    J A Heit
    C W Colwell
    C W Francis
    J S Ginsberg
    S D Berkowitz
    J Whipple
    G Peters
    AstraZeneca Arthroplasty Study Group
    1 October 2001
    2215-2221

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit